Global Neurovascular Devices Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Neurovascular Devices market size is predicted to grow from US$ 201 million in 2025 to US$ 280 million in 2031; it is expected to grow at a CAGR of 5.7% from 2025 to 2031.
Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.
Top players in the neurovascular devices market are Stryker Corporation and Medtronic, Johnson & Johnson, Terumo Corporation, Penumbra, Abbott Laboratories, W. L. Gore & Associates, Microport Scientific Corporation and some others are also key players in this field.
Geographically, the neurovascular devices market is classified into North America, Europe, Japan, China and The Rest. North America dominates the global market, followed by Europe and Japan.
On the basis of product, the neurovascular devices market is classified into four major segments—aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, support devices, and neurothrombectomy devices. The aneurysm coiling and embolization devices segment is the largest and accounts for about 37% of the global neurovascular devices market.
Neurovascular devices are widely used in hospitals, clinics and ambulatory surgical units.
LP Information, Inc. (LPI) ' newest research report, the “Neurovascular Devices Industry Forecast” looks at past sales and reviews total world Neurovascular Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Neurovascular Devices sales for 2025 through 2031. With Neurovascular Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurovascular Devices industry.
This Insight Report provides a comprehensive analysis of the global Neurovascular Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurovascular Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurovascular Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurovascular Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurovascular Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurovascular Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Neurovascular Devices market?
What factors are driving Neurovascular Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurovascular Devices market opportunities vary by end market size?
How does Neurovascular Devices break out by Type, by Application?
The global Neurovascular Devices market size is predicted to grow from US$ 201 million in 2025 to US$ 280 million in 2031; it is expected to grow at a CAGR of 5.7% from 2025 to 2031.
Neurovascular Devices refer to the tools that used to pass through the blood vessels to diagnose and treat diseases and conditions of the brain and nervous system rather than using open surgery. Neurovascular Devices comprise a large segment of medical devices, including embolic coils, neurovascular stents (carotid and intracranial stents), intravascular devices, neurothrombectomy devices, flow diverters, embolic protection device, balloons and stent retrievers.
Top players in the neurovascular devices market are Stryker Corporation and Medtronic, Johnson & Johnson, Terumo Corporation, Penumbra, Abbott Laboratories, W. L. Gore & Associates, Microport Scientific Corporation and some others are also key players in this field.
Geographically, the neurovascular devices market is classified into North America, Europe, Japan, China and The Rest. North America dominates the global market, followed by Europe and Japan.
On the basis of product, the neurovascular devices market is classified into four major segments—aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems, support devices, and neurothrombectomy devices. The aneurysm coiling and embolization devices segment is the largest and accounts for about 37% of the global neurovascular devices market.
Neurovascular devices are widely used in hospitals, clinics and ambulatory surgical units.
LP Information, Inc. (LPI) ' newest research report, the “Neurovascular Devices Industry Forecast” looks at past sales and reviews total world Neurovascular Devices sales in 2024, providing a comprehensive analysis by region and market sector of projected Neurovascular Devices sales for 2025 through 2031. With Neurovascular Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurovascular Devices industry.
This Insight Report provides a comprehensive analysis of the global Neurovascular Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurovascular Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurovascular Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurovascular Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurovascular Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurovascular Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Aneurysm Coiling & Embolization Devices
- Cerebral Balloon Angioplasty & Stenting Systems
- Support Devices
- Neurothrombectomy Devices
- Hospitals
- Clinics
- Ambulatory Surgical Units
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Stryker Corporation
- Johnson & Johnson
- Medtronic
- Terumo
- Penumbra
- Microport Scientific Corporation
- Abbott Vascular
- W. L. Gore & Associates
What is the 10-year outlook for the global Neurovascular Devices market?
What factors are driving Neurovascular Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurovascular Devices market opportunities vary by end market size?
How does Neurovascular Devices break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurovascular Devices Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Neurovascular Devices by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Neurovascular Devices by Country/Region, 2020, 2024 & 2031
2.2 Neurovascular Devices Segment by Type
2.2.1 Aneurysm Coiling & Embolization Devices
2.2.2 Cerebral Balloon Angioplasty & Stenting Systems
2.2.3 Support Devices
2.2.4 Neurothrombectomy Devices
2.3 Neurovascular Devices Sales by Type
2.3.1 Global Neurovascular Devices Sales Market Share by Type (2020-2025)
2.3.2 Global Neurovascular Devices Revenue and Market Share by Type (2020-2025)
2.3.3 Global Neurovascular Devices Sale Price by Type (2020-2025)
2.4 Neurovascular Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Units
2.5 Neurovascular Devices Sales by Application
2.5.1 Global Neurovascular Devices Sale Market Share by Application (2020-2025)
2.5.2 Global Neurovascular Devices Revenue and Market Share by Application (2020-2025)
2.5.3 Global Neurovascular Devices Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Neurovascular Devices Breakdown Data by Company
3.1.1 Global Neurovascular Devices Annual Sales by Company (2020-2025)
3.1.2 Global Neurovascular Devices Sales Market Share by Company (2020-2025)
3.2 Global Neurovascular Devices Annual Revenue by Company (2020-2025)
3.2.1 Global Neurovascular Devices Revenue by Company (2020-2025)
3.2.2 Global Neurovascular Devices Revenue Market Share by Company (2020-2025)
3.3 Global Neurovascular Devices Sale Price by Company
3.4 Key Manufacturers Neurovascular Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurovascular Devices Product Location Distribution
3.4.2 Players Neurovascular Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROVASCULAR DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Neurovascular Devices Market Size by Geographic Region (2020-2025)
4.1.1 Global Neurovascular Devices Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Neurovascular Devices Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Neurovascular Devices Market Size by Country/Region (2020-2025)
4.2.1 Global Neurovascular Devices Annual Sales by Country/Region (2020-2025)
4.2.2 Global Neurovascular Devices Annual Revenue by Country/Region (2020-2025)
4.3 Americas Neurovascular Devices Sales Growth
4.4 APAC Neurovascular Devices Sales Growth
4.5 Europe Neurovascular Devices Sales Growth
4.6 Middle East & Africa Neurovascular Devices Sales Growth
5 AMERICAS
5.1 Americas Neurovascular Devices Sales by Country
5.1.1 Americas Neurovascular Devices Sales by Country (2020-2025)
5.1.2 Americas Neurovascular Devices Revenue by Country (2020-2025)
5.2 Americas Neurovascular Devices Sales by Type (2020-2025)
5.3 Americas Neurovascular Devices Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurovascular Devices Sales by Region
6.1.1 APAC Neurovascular Devices Sales by Region (2020-2025)
6.1.2 APAC Neurovascular Devices Revenue by Region (2020-2025)
6.2 APAC Neurovascular Devices Sales by Type (2020-2025)
6.3 APAC Neurovascular Devices Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurovascular Devices by Country
7.1.1 Europe Neurovascular Devices Sales by Country (2020-2025)
7.1.2 Europe Neurovascular Devices Revenue by Country (2020-2025)
7.2 Europe Neurovascular Devices Sales by Type (2020-2025)
7.3 Europe Neurovascular Devices Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurovascular Devices by Country
8.1.1 Middle East & Africa Neurovascular Devices Sales by Country (2020-2025)
8.1.2 Middle East & Africa Neurovascular Devices Revenue by Country (2020-2025)
8.2 Middle East & Africa Neurovascular Devices Sales by Type (2020-2025)
8.3 Middle East & Africa Neurovascular Devices Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurovascular Devices
10.3 Manufacturing Process Analysis of Neurovascular Devices
10.4 Industry Chain Structure of Neurovascular Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurovascular Devices Distributors
11.3 Neurovascular Devices Customer
12 WORLD FORECAST REVIEW FOR NEUROVASCULAR DEVICES BY GEOGRAPHIC REGION
12.1 Global Neurovascular Devices Market Size Forecast by Region
12.1.1 Global Neurovascular Devices Forecast by Region (2026-2031)
12.1.2 Global Neurovascular Devices Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Neurovascular Devices Forecast by Type (2026-2031)
12.7 Global Neurovascular Devices Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Stryker Corporation
13.1.1 Stryker Corporation Company Information
13.1.2 Stryker Corporation Neurovascular Devices Product Portfolios and Specifications
13.1.3 Stryker Corporation Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Stryker Corporation Main Business Overview
13.1.5 Stryker Corporation Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Neurovascular Devices Product Portfolios and Specifications
13.2.3 Johnson & Johnson Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Neurovascular Devices Product Portfolios and Specifications
13.3.3 Medtronic Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Terumo
13.4.1 Terumo Company Information
13.4.2 Terumo Neurovascular Devices Product Portfolios and Specifications
13.4.3 Terumo Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Terumo Main Business Overview
13.4.5 Terumo Latest Developments
13.5 Penumbra
13.5.1 Penumbra Company Information
13.5.2 Penumbra Neurovascular Devices Product Portfolios and Specifications
13.5.3 Penumbra Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Penumbra Main Business Overview
13.5.5 Penumbra Latest Developments
13.6 Microport Scientific Corporation
13.6.1 Microport Scientific Corporation Company Information
13.6.2 Microport Scientific Corporation Neurovascular Devices Product Portfolios and Specifications
13.6.3 Microport Scientific Corporation Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Microport Scientific Corporation Main Business Overview
13.6.5 Microport Scientific Corporation Latest Developments
13.7 Abbott Vascular
13.7.1 Abbott Vascular Company Information
13.7.2 Abbott Vascular Neurovascular Devices Product Portfolios and Specifications
13.7.3 Abbott Vascular Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Abbott Vascular Main Business Overview
13.7.5 Abbott Vascular Latest Developments
13.8 W. L. Gore & Associates
13.8.1 W. L. Gore & Associates Company Information
13.8.2 W. L. Gore & Associates Neurovascular Devices Product Portfolios and Specifications
13.8.3 W. L. Gore & Associates Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 W. L. Gore & Associates Main Business Overview
13.8.5 W. L. Gore & Associates Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Neurovascular Devices Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Neurovascular Devices Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Aneurysm Coiling & Embolization Devices
Table 4. Major Players of Cerebral Balloon Angioplasty & Stenting Systems
Table 5. Major Players of Support Devices
Table 6. Major Players of Neurothrombectomy Devices
Table 7. Global Neurovascular Devices Sales byType (2020-2025) & (K Units)
Table 8. Global Neurovascular Devices Sales Market Share byType (2020-2025)
Table 9. Global Neurovascular Devices Revenue byType (2020-2025) & ($ million)
Table 10. Global Neurovascular Devices Revenue Market Share byType (2020-2025)
Table 11. Global Neurovascular Devices Sale Price byType (2020-2025) & (USD/Unit)
Table 12. Global Neurovascular Devices Sale by Application (2020-2025) & (K Units)
Table 13. Global Neurovascular Devices Sale Market Share by Application (2020-2025)
Table 14. Global Neurovascular Devices Revenue by Application (2020-2025) & ($ million)
Table 15. Global Neurovascular Devices Revenue Market Share by Application (2020-2025)
Table 16. Global Neurovascular Devices Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Neurovascular Devices Sales by Company (2020-2025) & (K Units)
Table 18. Global Neurovascular Devices Sales Market Share by Company (2020-2025)
Table 19. Global Neurovascular Devices Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Neurovascular Devices Revenue Market Share by Company (2020-2025)
Table 21. Global Neurovascular Devices Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Neurovascular Devices Producing Area Distribution and Sales Area
Table 23. Players Neurovascular Devices Products Offered
Table 24. Neurovascular Devices Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Neurovascular Devices Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Neurovascular Devices Sales Market Share Geographic Region (2020-2025)
Table 29. Global Neurovascular Devices Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Neurovascular Devices Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Neurovascular Devices Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Neurovascular Devices Sales Market Share by Country/Region (2020-2025)
Table 33. Global Neurovascular Devices Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Neurovascular Devices Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Neurovascular Devices Sales by Country (2020-2025) & (K Units)
Table 36. Americas Neurovascular Devices Sales Market Share by Country (2020-2025)
Table 37. Americas Neurovascular Devices Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Neurovascular Devices Sales byType (2020-2025) & (K Units)
Table 39. Americas Neurovascular Devices Sales by Application (2020-2025) & (K Units)
Table 40. APAC Neurovascular Devices Sales by Region (2020-2025) & (K Units)
Table 41. APAC Neurovascular Devices Sales Market Share by Region (2020-2025)
Table 42. APAC Neurovascular Devices Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Neurovascular Devices Sales byType (2020-2025) & (K Units)
Table 44. APAC Neurovascular Devices Sales by Application (2020-2025) & (K Units)
Table 45. Europe Neurovascular Devices Sales by Country (2020-2025) & (K Units)
Table 46. Europe Neurovascular Devices Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Neurovascular Devices Sales byType (2020-2025) & (K Units)
Table 48. Europe Neurovascular Devices Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Neurovascular Devices Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Neurovascular Devices Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Neurovascular Devices Sales byType (2020-2025) & (K Units)
Table 52. Middle East & Africa Neurovascular Devices Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Neurovascular Devices
Table 54. Key Market Challenges & Risks of Neurovascular Devices
Table 55. Key IndustryTrends of Neurovascular Devices
Table 56. Neurovascular Devices Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Neurovascular Devices Distributors List
Table 59. Neurovascular Devices Customer List
Table 60. Global Neurovascular Devices SalesForecast by Region (2026-2031) & (K Units)
Table 61. Global Neurovascular Devices RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Neurovascular Devices SalesForecast by Country (2026-2031) & (K Units)
Table 63. Americas Neurovascular Devices Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Neurovascular Devices SalesForecast by Region (2026-2031) & (K Units)
Table 65. APAC Neurovascular Devices Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Neurovascular Devices SalesForecast by Country (2026-2031) & (K Units)
Table 67. Europe Neurovascular Devices RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Neurovascular Devices SalesForecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Neurovascular Devices RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Neurovascular Devices SalesForecast byType (2026-2031) & (K Units)
Table 71. Global Neurovascular Devices RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Neurovascular Devices SalesForecast by Application (2026-2031) & (K Units)
Table 73. Global Neurovascular Devices RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Stryker Corporation Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 75. Stryker Corporation Neurovascular Devices Product Portfolios and Specifications
Table 76. Stryker Corporation Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Stryker Corporation Main Business
Table 78. Stryker Corporation Latest Developments
Table 79. Johnson & Johnson Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 80. Johnson & Johnson Neurovascular Devices Product Portfolios and Specifications
Table 81. Johnson & Johnson Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Johnson & Johnson Main Business
Table 83. Johnson & Johnson Latest Developments
Table 84. Medtronic Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 85. Medtronic Neurovascular Devices Product Portfolios and Specifications
Table 86. Medtronic Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Medtronic Main Business
Table 88. Medtronic Latest Developments
Table 89.Terumo Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 90.Terumo Neurovascular Devices Product Portfolios and Specifications
Table 91.Terumo Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92.Terumo Main Business
Table 93.Terumo Latest Developments
Table 94. Penumbra Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 95. Penumbra Neurovascular Devices Product Portfolios and Specifications
Table 96. Penumbra Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Penumbra Main Business
Table 98. Penumbra Latest Developments
Table 99. Microport Scientific Corporation Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 100. Microport Scientific Corporation Neurovascular Devices Product Portfolios and Specifications
Table 101. Microport Scientific Corporation Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Microport Scientific Corporation Main Business
Table 103. Microport Scientific Corporation Latest Developments
Table 104. Abbott Vascular Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 105. Abbott Vascular Neurovascular Devices Product Portfolios and Specifications
Table 106. Abbott Vascular Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Abbott Vascular Main Business
Table 108. Abbott Vascular Latest Developments
Table 109. W. L. Gore & Associates Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 110. W. L. Gore & Associates Neurovascular Devices Product Portfolios and Specifications
Table 111. W. L. Gore & Associates Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. W. L. Gore & Associates Main Business
Table 113. W. L. Gore & Associates Latest Developments
LIST OFFIGURES
Figure 1. Picture of Neurovascular Devices
Figure 2. Neurovascular Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurovascular Devices Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Neurovascular Devices Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Neurovascular Devices Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Neurovascular Devices Sales Market Share by Country/Region (2024)
Figure 10. Neurovascular Devices Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Aneurysm Coiling & Embolization Devices
Figure 12. Product Picture of Cerebral Balloon Angioplasty & Stenting Systems
Figure 13. Product Picture of Support Devices
Figure 14. Product Picture of Neurothrombectomy Devices
Figure 15. Global Neurovascular Devices Sales Market Share byType in 2025
Figure 16. Global Neurovascular Devices Revenue Market Share byType (2020-2025)
Figure 17. Neurovascular Devices Consumed in Hospitals
Figure 18. Global Neurovascular Devices Market: Hospitals (2020-2025) & (K Units)
Figure 19. Neurovascular Devices Consumed in Clinics
Figure 20. Global Neurovascular Devices Market: Clinics (2020-2025) & (K Units)
Figure 21. Neurovascular Devices Consumed in Ambulatory Surgical Units
Figure 22. Global Neurovascular Devices Market: Ambulatory Surgical Units (2020-2025) & (K Units)
Figure 23. Global Neurovascular Devices Sale Market Share by Application (2024)
Figure 24. Global Neurovascular Devices Revenue Market Share by Application in 2025
Figure 25. Neurovascular Devices Sales by Company in 2025 (K Units)
Figure 26. Global Neurovascular Devices Sales Market Share by Company in 2025
Figure 27. Neurovascular Devices Revenue by Company in 2025 ($ millions)
Figure 28. Global Neurovascular Devices Revenue Market Share by Company in 2025
Figure 29. Global Neurovascular Devices Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Neurovascular Devices Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Neurovascular Devices Sales 2020-2025 (K Units)
Figure 32. Americas Neurovascular Devices Revenue 2020-2025 ($ millions)
Figure 33. APAC Neurovascular Devices Sales 2020-2025 (K Units)
Figure 34. APAC Neurovascular Devices Revenue 2020-2025 ($ millions)
Figure 35. Europe Neurovascular Devices Sales 2020-2025 (K Units)
Figure 36. Europe Neurovascular Devices Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Neurovascular Devices Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Neurovascular Devices Revenue 2020-2025 ($ millions)
Figure 39. Americas Neurovascular Devices Sales Market Share by Country in 2025
Figure 40. Americas Neurovascular Devices Revenue Market Share by Country (2020-2025)
Figure 41. Americas Neurovascular Devices Sales Market Share byType (2020-2025)
Figure 42. Americas Neurovascular Devices Sales Market Share by Application (2020-2025)
Figure 43. United States Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Neurovascular Devices Sales Market Share by Region in 2025
Figure 48. APAC Neurovascular Devices Revenue Market Share by Region (2020-2025)
Figure 49. APAC Neurovascular Devices Sales Market Share byType (2020-2025)
Figure 50. APAC Neurovascular Devices Sales Market Share by Application (2020-2025)
Figure 51. China Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 55. India Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Neurovascular Devices Sales Market Share by Country in 2025
Figure 59. Europe Neurovascular Devices Revenue Market Share by Country (2020-2025)
Figure 60. Europe Neurovascular Devices Sales Market Share byType (2020-2025)
Figure 61. Europe Neurovascular Devices Sales Market Share by Application (2020-2025)
Figure 62. Germany Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 63.France Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Neurovascular Devices Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Neurovascular Devices Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Neurovascular Devices Sales Market Share by Application (2020-2025)
Figure 70. Egypt Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Neurovascular Devices in 2025
Figure 76. Manufacturing Process Analysis of Neurovascular Devices
Figure 77. Industry Chain Structure of Neurovascular Devices
Figure 78. Channels of Distribution
Figure 79. Global Neurovascular Devices Sales MarketForecast by Region (2026-2031)
Figure 80. Global Neurovascular Devices Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Neurovascular Devices Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Neurovascular Devices Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Neurovascular Devices Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Neurovascular Devices Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurovascular Devices Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Neurovascular Devices by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Neurovascular Devices by Country/Region, 2020, 2024 & 2031
2.2 Neurovascular Devices Segment by Type
2.2.1 Aneurysm Coiling & Embolization Devices
2.2.2 Cerebral Balloon Angioplasty & Stenting Systems
2.2.3 Support Devices
2.2.4 Neurothrombectomy Devices
2.3 Neurovascular Devices Sales by Type
2.3.1 Global Neurovascular Devices Sales Market Share by Type (2020-2025)
2.3.2 Global Neurovascular Devices Revenue and Market Share by Type (2020-2025)
2.3.3 Global Neurovascular Devices Sale Price by Type (2020-2025)
2.4 Neurovascular Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Units
2.5 Neurovascular Devices Sales by Application
2.5.1 Global Neurovascular Devices Sale Market Share by Application (2020-2025)
2.5.2 Global Neurovascular Devices Revenue and Market Share by Application (2020-2025)
2.5.3 Global Neurovascular Devices Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Neurovascular Devices Breakdown Data by Company
3.1.1 Global Neurovascular Devices Annual Sales by Company (2020-2025)
3.1.2 Global Neurovascular Devices Sales Market Share by Company (2020-2025)
3.2 Global Neurovascular Devices Annual Revenue by Company (2020-2025)
3.2.1 Global Neurovascular Devices Revenue by Company (2020-2025)
3.2.2 Global Neurovascular Devices Revenue Market Share by Company (2020-2025)
3.3 Global Neurovascular Devices Sale Price by Company
3.4 Key Manufacturers Neurovascular Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurovascular Devices Product Location Distribution
3.4.2 Players Neurovascular Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROVASCULAR DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Neurovascular Devices Market Size by Geographic Region (2020-2025)
4.1.1 Global Neurovascular Devices Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Neurovascular Devices Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Neurovascular Devices Market Size by Country/Region (2020-2025)
4.2.1 Global Neurovascular Devices Annual Sales by Country/Region (2020-2025)
4.2.2 Global Neurovascular Devices Annual Revenue by Country/Region (2020-2025)
4.3 Americas Neurovascular Devices Sales Growth
4.4 APAC Neurovascular Devices Sales Growth
4.5 Europe Neurovascular Devices Sales Growth
4.6 Middle East & Africa Neurovascular Devices Sales Growth
5 AMERICAS
5.1 Americas Neurovascular Devices Sales by Country
5.1.1 Americas Neurovascular Devices Sales by Country (2020-2025)
5.1.2 Americas Neurovascular Devices Revenue by Country (2020-2025)
5.2 Americas Neurovascular Devices Sales by Type (2020-2025)
5.3 Americas Neurovascular Devices Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurovascular Devices Sales by Region
6.1.1 APAC Neurovascular Devices Sales by Region (2020-2025)
6.1.2 APAC Neurovascular Devices Revenue by Region (2020-2025)
6.2 APAC Neurovascular Devices Sales by Type (2020-2025)
6.3 APAC Neurovascular Devices Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurovascular Devices by Country
7.1.1 Europe Neurovascular Devices Sales by Country (2020-2025)
7.1.2 Europe Neurovascular Devices Revenue by Country (2020-2025)
7.2 Europe Neurovascular Devices Sales by Type (2020-2025)
7.3 Europe Neurovascular Devices Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurovascular Devices by Country
8.1.1 Middle East & Africa Neurovascular Devices Sales by Country (2020-2025)
8.1.2 Middle East & Africa Neurovascular Devices Revenue by Country (2020-2025)
8.2 Middle East & Africa Neurovascular Devices Sales by Type (2020-2025)
8.3 Middle East & Africa Neurovascular Devices Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurovascular Devices
10.3 Manufacturing Process Analysis of Neurovascular Devices
10.4 Industry Chain Structure of Neurovascular Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurovascular Devices Distributors
11.3 Neurovascular Devices Customer
12 WORLD FORECAST REVIEW FOR NEUROVASCULAR DEVICES BY GEOGRAPHIC REGION
12.1 Global Neurovascular Devices Market Size Forecast by Region
12.1.1 Global Neurovascular Devices Forecast by Region (2026-2031)
12.1.2 Global Neurovascular Devices Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Neurovascular Devices Forecast by Type (2026-2031)
12.7 Global Neurovascular Devices Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Stryker Corporation
13.1.1 Stryker Corporation Company Information
13.1.2 Stryker Corporation Neurovascular Devices Product Portfolios and Specifications
13.1.3 Stryker Corporation Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Stryker Corporation Main Business Overview
13.1.5 Stryker Corporation Latest Developments
13.2 Johnson & Johnson
13.2.1 Johnson & Johnson Company Information
13.2.2 Johnson & Johnson Neurovascular Devices Product Portfolios and Specifications
13.2.3 Johnson & Johnson Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Johnson & Johnson Main Business Overview
13.2.5 Johnson & Johnson Latest Developments
13.3 Medtronic
13.3.1 Medtronic Company Information
13.3.2 Medtronic Neurovascular Devices Product Portfolios and Specifications
13.3.3 Medtronic Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Medtronic Main Business Overview
13.3.5 Medtronic Latest Developments
13.4 Terumo
13.4.1 Terumo Company Information
13.4.2 Terumo Neurovascular Devices Product Portfolios and Specifications
13.4.3 Terumo Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Terumo Main Business Overview
13.4.5 Terumo Latest Developments
13.5 Penumbra
13.5.1 Penumbra Company Information
13.5.2 Penumbra Neurovascular Devices Product Portfolios and Specifications
13.5.3 Penumbra Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Penumbra Main Business Overview
13.5.5 Penumbra Latest Developments
13.6 Microport Scientific Corporation
13.6.1 Microport Scientific Corporation Company Information
13.6.2 Microport Scientific Corporation Neurovascular Devices Product Portfolios and Specifications
13.6.3 Microport Scientific Corporation Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Microport Scientific Corporation Main Business Overview
13.6.5 Microport Scientific Corporation Latest Developments
13.7 Abbott Vascular
13.7.1 Abbott Vascular Company Information
13.7.2 Abbott Vascular Neurovascular Devices Product Portfolios and Specifications
13.7.3 Abbott Vascular Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Abbott Vascular Main Business Overview
13.7.5 Abbott Vascular Latest Developments
13.8 W. L. Gore & Associates
13.8.1 W. L. Gore & Associates Company Information
13.8.2 W. L. Gore & Associates Neurovascular Devices Product Portfolios and Specifications
13.8.3 W. L. Gore & Associates Neurovascular Devices Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 W. L. Gore & Associates Main Business Overview
13.8.5 W. L. Gore & Associates Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Neurovascular Devices Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Neurovascular Devices Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Aneurysm Coiling & Embolization Devices
Table 4. Major Players of Cerebral Balloon Angioplasty & Stenting Systems
Table 5. Major Players of Support Devices
Table 6. Major Players of Neurothrombectomy Devices
Table 7. Global Neurovascular Devices Sales byType (2020-2025) & (K Units)
Table 8. Global Neurovascular Devices Sales Market Share byType (2020-2025)
Table 9. Global Neurovascular Devices Revenue byType (2020-2025) & ($ million)
Table 10. Global Neurovascular Devices Revenue Market Share byType (2020-2025)
Table 11. Global Neurovascular Devices Sale Price byType (2020-2025) & (USD/Unit)
Table 12. Global Neurovascular Devices Sale by Application (2020-2025) & (K Units)
Table 13. Global Neurovascular Devices Sale Market Share by Application (2020-2025)
Table 14. Global Neurovascular Devices Revenue by Application (2020-2025) & ($ million)
Table 15. Global Neurovascular Devices Revenue Market Share by Application (2020-2025)
Table 16. Global Neurovascular Devices Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. Global Neurovascular Devices Sales by Company (2020-2025) & (K Units)
Table 18. Global Neurovascular Devices Sales Market Share by Company (2020-2025)
Table 19. Global Neurovascular Devices Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Neurovascular Devices Revenue Market Share by Company (2020-2025)
Table 21. Global Neurovascular Devices Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key Manufacturers Neurovascular Devices Producing Area Distribution and Sales Area
Table 23. Players Neurovascular Devices Products Offered
Table 24. Neurovascular Devices Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Neurovascular Devices Sales by Geographic Region (2020-2025) & (K Units)
Table 28. Global Neurovascular Devices Sales Market Share Geographic Region (2020-2025)
Table 29. Global Neurovascular Devices Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Neurovascular Devices Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Neurovascular Devices Sales by Country/Region (2020-2025) & (K Units)
Table 32. Global Neurovascular Devices Sales Market Share by Country/Region (2020-2025)
Table 33. Global Neurovascular Devices Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Neurovascular Devices Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Neurovascular Devices Sales by Country (2020-2025) & (K Units)
Table 36. Americas Neurovascular Devices Sales Market Share by Country (2020-2025)
Table 37. Americas Neurovascular Devices Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Neurovascular Devices Sales byType (2020-2025) & (K Units)
Table 39. Americas Neurovascular Devices Sales by Application (2020-2025) & (K Units)
Table 40. APAC Neurovascular Devices Sales by Region (2020-2025) & (K Units)
Table 41. APAC Neurovascular Devices Sales Market Share by Region (2020-2025)
Table 42. APAC Neurovascular Devices Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Neurovascular Devices Sales byType (2020-2025) & (K Units)
Table 44. APAC Neurovascular Devices Sales by Application (2020-2025) & (K Units)
Table 45. Europe Neurovascular Devices Sales by Country (2020-2025) & (K Units)
Table 46. Europe Neurovascular Devices Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Neurovascular Devices Sales byType (2020-2025) & (K Units)
Table 48. Europe Neurovascular Devices Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & Africa Neurovascular Devices Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & Africa Neurovascular Devices Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Neurovascular Devices Sales byType (2020-2025) & (K Units)
Table 52. Middle East & Africa Neurovascular Devices Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Neurovascular Devices
Table 54. Key Market Challenges & Risks of Neurovascular Devices
Table 55. Key IndustryTrends of Neurovascular Devices
Table 56. Neurovascular Devices Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Neurovascular Devices Distributors List
Table 59. Neurovascular Devices Customer List
Table 60. Global Neurovascular Devices SalesForecast by Region (2026-2031) & (K Units)
Table 61. Global Neurovascular Devices RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Neurovascular Devices SalesForecast by Country (2026-2031) & (K Units)
Table 63. Americas Neurovascular Devices Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Neurovascular Devices SalesForecast by Region (2026-2031) & (K Units)
Table 65. APAC Neurovascular Devices Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Neurovascular Devices SalesForecast by Country (2026-2031) & (K Units)
Table 67. Europe Neurovascular Devices RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Neurovascular Devices SalesForecast by Country (2026-2031) & (K Units)
Table 69. Middle East & Africa Neurovascular Devices RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Neurovascular Devices SalesForecast byType (2026-2031) & (K Units)
Table 71. Global Neurovascular Devices RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Neurovascular Devices SalesForecast by Application (2026-2031) & (K Units)
Table 73. Global Neurovascular Devices RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Stryker Corporation Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 75. Stryker Corporation Neurovascular Devices Product Portfolios and Specifications
Table 76. Stryker Corporation Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Stryker Corporation Main Business
Table 78. Stryker Corporation Latest Developments
Table 79. Johnson & Johnson Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 80. Johnson & Johnson Neurovascular Devices Product Portfolios and Specifications
Table 81. Johnson & Johnson Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Johnson & Johnson Main Business
Table 83. Johnson & Johnson Latest Developments
Table 84. Medtronic Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 85. Medtronic Neurovascular Devices Product Portfolios and Specifications
Table 86. Medtronic Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Medtronic Main Business
Table 88. Medtronic Latest Developments
Table 89.Terumo Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 90.Terumo Neurovascular Devices Product Portfolios and Specifications
Table 91.Terumo Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92.Terumo Main Business
Table 93.Terumo Latest Developments
Table 94. Penumbra Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 95. Penumbra Neurovascular Devices Product Portfolios and Specifications
Table 96. Penumbra Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Penumbra Main Business
Table 98. Penumbra Latest Developments
Table 99. Microport Scientific Corporation Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 100. Microport Scientific Corporation Neurovascular Devices Product Portfolios and Specifications
Table 101. Microport Scientific Corporation Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Microport Scientific Corporation Main Business
Table 103. Microport Scientific Corporation Latest Developments
Table 104. Abbott Vascular Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 105. Abbott Vascular Neurovascular Devices Product Portfolios and Specifications
Table 106. Abbott Vascular Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Abbott Vascular Main Business
Table 108. Abbott Vascular Latest Developments
Table 109. W. L. Gore & Associates Basic Information, Neurovascular Devices Manufacturing Base, Sales Area and Its Competitors
Table 110. W. L. Gore & Associates Neurovascular Devices Product Portfolios and Specifications
Table 111. W. L. Gore & Associates Neurovascular Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. W. L. Gore & Associates Main Business
Table 113. W. L. Gore & Associates Latest Developments
LIST OFFIGURES
Figure 1. Picture of Neurovascular Devices
Figure 2. Neurovascular Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurovascular Devices Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Neurovascular Devices Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Neurovascular Devices Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Neurovascular Devices Sales Market Share by Country/Region (2024)
Figure 10. Neurovascular Devices Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Aneurysm Coiling & Embolization Devices
Figure 12. Product Picture of Cerebral Balloon Angioplasty & Stenting Systems
Figure 13. Product Picture of Support Devices
Figure 14. Product Picture of Neurothrombectomy Devices
Figure 15. Global Neurovascular Devices Sales Market Share byType in 2025
Figure 16. Global Neurovascular Devices Revenue Market Share byType (2020-2025)
Figure 17. Neurovascular Devices Consumed in Hospitals
Figure 18. Global Neurovascular Devices Market: Hospitals (2020-2025) & (K Units)
Figure 19. Neurovascular Devices Consumed in Clinics
Figure 20. Global Neurovascular Devices Market: Clinics (2020-2025) & (K Units)
Figure 21. Neurovascular Devices Consumed in Ambulatory Surgical Units
Figure 22. Global Neurovascular Devices Market: Ambulatory Surgical Units (2020-2025) & (K Units)
Figure 23. Global Neurovascular Devices Sale Market Share by Application (2024)
Figure 24. Global Neurovascular Devices Revenue Market Share by Application in 2025
Figure 25. Neurovascular Devices Sales by Company in 2025 (K Units)
Figure 26. Global Neurovascular Devices Sales Market Share by Company in 2025
Figure 27. Neurovascular Devices Revenue by Company in 2025 ($ millions)
Figure 28. Global Neurovascular Devices Revenue Market Share by Company in 2025
Figure 29. Global Neurovascular Devices Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Neurovascular Devices Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Neurovascular Devices Sales 2020-2025 (K Units)
Figure 32. Americas Neurovascular Devices Revenue 2020-2025 ($ millions)
Figure 33. APAC Neurovascular Devices Sales 2020-2025 (K Units)
Figure 34. APAC Neurovascular Devices Revenue 2020-2025 ($ millions)
Figure 35. Europe Neurovascular Devices Sales 2020-2025 (K Units)
Figure 36. Europe Neurovascular Devices Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Neurovascular Devices Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Neurovascular Devices Revenue 2020-2025 ($ millions)
Figure 39. Americas Neurovascular Devices Sales Market Share by Country in 2025
Figure 40. Americas Neurovascular Devices Revenue Market Share by Country (2020-2025)
Figure 41. Americas Neurovascular Devices Sales Market Share byType (2020-2025)
Figure 42. Americas Neurovascular Devices Sales Market Share by Application (2020-2025)
Figure 43. United States Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Neurovascular Devices Sales Market Share by Region in 2025
Figure 48. APAC Neurovascular Devices Revenue Market Share by Region (2020-2025)
Figure 49. APAC Neurovascular Devices Sales Market Share byType (2020-2025)
Figure 50. APAC Neurovascular Devices Sales Market Share by Application (2020-2025)
Figure 51. China Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 55. India Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Neurovascular Devices Sales Market Share by Country in 2025
Figure 59. Europe Neurovascular Devices Revenue Market Share by Country (2020-2025)
Figure 60. Europe Neurovascular Devices Sales Market Share byType (2020-2025)
Figure 61. Europe Neurovascular Devices Sales Market Share by Application (2020-2025)
Figure 62. Germany Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 63.France Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Neurovascular Devices Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Neurovascular Devices Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Neurovascular Devices Sales Market Share by Application (2020-2025)
Figure 70. Egypt Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Neurovascular Devices Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Neurovascular Devices in 2025
Figure 76. Manufacturing Process Analysis of Neurovascular Devices
Figure 77. Industry Chain Structure of Neurovascular Devices
Figure 78. Channels of Distribution
Figure 79. Global Neurovascular Devices Sales MarketForecast by Region (2026-2031)
Figure 80. Global Neurovascular Devices Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Neurovascular Devices Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Neurovascular Devices Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Neurovascular Devices Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Neurovascular Devices Revenue Market ShareForecast by Application (2026-2031)
